Carson Wealth (CWM LLC)’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
BTW
Carson Wealth (CWM LLC)'s AMPH Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its Amphastar Pharmaceuticals (AMPH) stake by 61% in Q1 2026, selling an estimated $25.1K and leaving 658 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4679.
Carson Wealth (CWM LLC) first reported a position in AMPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $103K in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Carson Wealth (CWM LLC) held 658 shares of Amphastar Pharmaceuticals worth $12.9K as of Q1 2026.
- Carson Wealth (CWM LLC) sold 1,025 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $25.1K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4679 holding.
- Carson Wealth (CWM LLC) first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
- Carson Wealth (CWM LLC)'s Amphastar Pharmaceuticals position peaked at $103K in Q2 2025.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.